These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

300 related items for PubMed ID: 21328340

  • 1. TMZ-induced PrPc/par-4 interaction promotes the survival of human glioma cells.
    Zhuang D, Liu Y, Mao Y, Gao L, Zhang H, Luan S, Huang F, Li Q.
    Int J Cancer; 2012 Jan 15; 130(2):309-18. PubMed ID: 21328340
    [Abstract] [Full Text] [Related]

  • 2. Apoptosis in malignant glioma cells triggered by the temozolomide-induced DNA lesion O6-methylguanine.
    Roos WP, Batista LF, Naumann SC, Wick W, Weller M, Menck CF, Kaina B.
    Oncogene; 2007 Jan 11; 26(2):186-97. PubMed ID: 16819506
    [Abstract] [Full Text] [Related]

  • 3. Resveratrol enhances the therapeutic effect of temozolomide against malignant glioma in vitro and in vivo by inhibiting autophagy.
    Lin CJ, Lee CC, Shih YL, Lin TY, Wang SH, Lin YF, Shih CM.
    Free Radic Biol Med; 2012 Jan 15; 52(2):377-91. PubMed ID: 22094224
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Connexin43 confers Temozolomide resistance in human glioma cells by modulating the mitochondrial apoptosis pathway.
    Gielen PR, Aftab Q, Ma N, Chen VC, Hong X, Lozinsky S, Naus CC, Sin WC.
    Neuropharmacology; 2013 Dec 15; 75():539-48. PubMed ID: 23688923
    [Abstract] [Full Text] [Related]

  • 8. Cooperative function of Chk1 and p38 pathways in activating G2 arrest following exposure to temozolomide.
    Hirose Y, Katayama M, Berger MS, Pieper RO.
    J Neurosurg; 2004 Jun 15; 100(6):1060-5. PubMed ID: 15200121
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Inhibition of prolyl 4-hydroxylase, beta polypeptide (P4HB) attenuates temozolomide resistance in malignant glioma via the endoplasmic reticulum stress response (ERSR) pathways.
    Sun S, Lee D, Ho AS, Pu JK, Zhang XQ, Lee NP, Day PJ, Lui WM, Fung CF, Leung GK.
    Neuro Oncol; 2013 May 15; 15(5):562-77. PubMed ID: 23444257
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Downregulation of BRCA1-BRCA2-containing complex subunit 3 sensitizes glioma cells to temozolomide.
    Chai KM, Wang CY, Liaw HJ, Fang KM, Yang CS, Tzeng SF.
    Oncotarget; 2014 Nov 15; 5(21):10901-15. PubMed ID: 25337721
    [Abstract] [Full Text] [Related]

  • 13. Potential application of temozolomide in mesenchymal stem cell-based TRAIL gene therapy against malignant glioma.
    Kim SM, Woo JS, Jeong CH, Ryu CH, Jang JD, Jeun SS.
    Stem Cells Transl Med; 2014 Feb 15; 3(2):172-82. PubMed ID: 24436439
    [Abstract] [Full Text] [Related]

  • 14. KLF8 Promotes Temozolomide Resistance in Glioma Cells via β-Catenin Activation.
    Yu G, Wu F, Wang E.
    Cell Physiol Biochem; 2016 Feb 15; 38(4):1596-604. PubMed ID: 27081861
    [Abstract] [Full Text] [Related]

  • 15. Guanosine promotes cytotoxicity via adenosine receptors and induces apoptosis in temozolomide-treated A172 glioma cells.
    Oliveira KA, Dal-Cim TA, Lopes FG, Nedel CB, Tasca CI.
    Purinergic Signal; 2017 Sep 15; 13(3):305-318. PubMed ID: 28536931
    [Abstract] [Full Text] [Related]

  • 16. β-Asarone promotes Temozolomide's entry into glioma cells and decreases the expression of P-glycoprotein and MDR1.
    Wang N, Zhang Q, Ning B, Luo L, Fang Y.
    Biomed Pharmacother; 2017 Jun 15; 90():368-374. PubMed ID: 28380412
    [Abstract] [Full Text] [Related]

  • 17. NRF2 and glutathione are key resistance mediators to temozolomide in glioma and melanoma cells.
    Rocha CR, Kajitani GS, Quinet A, Fortunato RS, Menck CF.
    Oncotarget; 2016 Jul 26; 7(30):48081-48092. PubMed ID: 27344172
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. MiR-21 protected human glioblastoma U87MG cells from chemotherapeutic drug temozolomide induced apoptosis by decreasing Bax/Bcl-2 ratio and caspase-3 activity.
    Shi L, Chen J, Yang J, Pan T, Zhang S, Wang Z.
    Brain Res; 2010 Sep 17; 1352():255-64. PubMed ID: 20633539
    [Abstract] [Full Text] [Related]

  • 20. Role of autophagy in temozolomide-induced cytotoxicity for malignant glioma cells.
    Kanzawa T, Germano IM, Komata T, Ito H, Kondo Y, Kondo S.
    Cell Death Differ; 2004 Apr 17; 11(4):448-57. PubMed ID: 14713959
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.